Latest Patents News

Page 14 of 104
Image Resources NL’s CEO Patrick Mutz will resign at the end of August 2026, with Chair Winston Lee stepping in as Executive Chair during the leadership transition. The company continues to operate its Atlas project while exploring innovative synthetic rutile processing.
Maxwell Dee
Maxwell Dee
17 Aug 2026
Amcor’s FY2026 results reflect the full impact of its 2025 Berry Global acquisition, with net sales soaring 57% to $23.5 billion and net income more than doubling to $1.1 billion. The company also announced a fiscal year-end change and a raised dividend.
Victor Sage
Victor Sage
17 Aug 2026
Dimerix has secured full sponsorship of the US Investigational New Drug application for its Phase 2-ready kidney drug DMX-652, setting the stage for a clinical trial targeting acute kidney injury in late 2026.
Ada Torres
Ada Torres
17 Aug 2026
Hazer Group and KBR have secured a paid pre-feasibility study with a leading Japanese power utility to explore large-scale deployment of methane pyrolysis technology, reinforcing Hazer's foothold in Japan's clean hydrogen market.
Maxwell Dee
Maxwell Dee
17 Aug 2026
Temas Resources posted a CAD 2.63 million loss for H1 2026, driven by ramped-up exploration and RCL technology development, while securing $1.5 million in fresh funding and signing initial RCL licensing contracts.
Maxwell Dee
Maxwell Dee
17 Aug 2026
Diablo Resources has secured an 80% stake in the historic Horn Silver Project in Utah, unlocking a portfolio of high-grade silver, gold, copper, and antimony targets. The acquisition complements its nearby Star Range assets and aligns with US critical minerals priorities.
Maxwell Dee
Maxwell Dee
17 Aug 2026
Ainsworth Game Technology has locked in a critical patent licence agreement with Aristocrat, granting rights to key gaming features and responsible gaming technologies in Australia while settling past patent disputes.
Victor Sage
Victor Sage
14 Aug 2026
Papyrus Australia has arranged a further $500,000 in unsecured loan facilities from four sophisticated investors, with conversion to unsecured convertible notes subject to shareholder approval at the 2026 AGM.
Victor Sage
Victor Sage
14 Aug 2026
ResMed Inc. posted a 10% rise in fiscal 2026 revenue to $5.65 billion, bolstered by the acquisition of Noctrix Health and an agreement to sell its MatrixCare business. The company continues to invest in AI-powered digital health solutions amid ongoing patent litigation and a shifting regulatory landscape.
Ada Torres
Ada Torres
14 Aug 2026
Proteomics International has achieved a key patent acceptance in Australia for its PromarkerEndo blood test, reinforcing its intellectual property portfolio and commercialisation strategy in a major healthcare market.
Ada Torres
Ada Torres
13 Aug 2026
NeuroScientific Biopharmaceuticals (ASX:NSB) has locked in a key FDA Pre-IND meeting for late August, advancing its Phase 2 trial plans for StemSmart™ targeting refractory Crohn’s disease in the US and Australia.
Ada Torres
Ada Torres
13 Aug 2026
InFocus Group Holdings has rolled out a major upgrade to its Codexa sweepstakes casino platform, introducing a VIP-style player experience and a proprietary AI-driven compliance engine designed to streamline operations and reduce costs for white-label operators.
Sophie Babbage
Sophie Babbage
12 Aug 2026

Browse the archive

Full archive